Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA

Journal of Infectious Diseases

Volumn 190, Issue 2, 2004, Pages 311-317

  Meka, Venkata G ^a,c   Pillai, Satish K ^a   Sakoulas, George ^b   Wennersten, Christine ^a   Venkataraman, Lata ^a   DeGirolami, Paola C ^a   Eliopoulos, George M ^a   Moellering Jr , Robert C ^a   Gold, Howard S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Crystal Run Healthcare   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE LOSS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RNA GENE; WILD TYPE;

ACETAMIDES; ANTI-INFECTIVE AGENTS; BLOOD; BLOTTING, SOUTHERN; CHROMOSOMES, BACTERIAL; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; GENE DELETION; GENE DOSAGE; GENES, RRNA; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MUTATION; OXAZOLIDINONES; POINT MUTATION; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 3242683097     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/421471     Document Type: Article

References (30)

1. Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001; 32:108-15.
2. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002 case report. MMWR Morb Mortal Wkly Rep 2002; 51:902.
3. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:565-7.
4. Shinabarger DL. Mechanism of action of the oxazolidinone antibacterial agents. Expert Opin Investig Drugs 1999; 8:1195-202.
5. Aoki H, Ke L, Poppe SM, et al. Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes. Antimicrob Agents Chemother 2002; 46:1080-5.
6. Kloss P, Xiong L, Shinabarger DL, Mankin AS. Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. J Mol Biol 1999; 294:93-101.
7. Prystowsky J, Siddiqui F, Chosay J, et al. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 2001; 45:2154-6.
8. Wada A, Ohta H, Kulthanan K, Hiramatsu K. Molecular cloning and mapping of 16S-23S rRNA gene complexes of Staphylococcus aureus. J Bacteriol 1993; 175:7483-7.
9. Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001; 358:207-8.
10. Pillai SK, Sakoulas G, Wennersten C, et al. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis 2002; 186:1603-7.
11. Wilson P, Andrews JA, Charlesworth R, et al. Linezolid resistance in clinical isolates of Staphylococcus aureus. J Antimicrob Chemother 2003; 51:186-1.
12. Swaney SM, Shinabarger DL, Schaadt RD, Bock BH, Slightom JL, Zurenko GE. Oxazolidinone resistance is associated with a mutation in the peptidyl transferase region of 23S rRNA [abstract C-104]. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 1998:98-9.
13. Marshall SH, Donskey CJ, Hutton-Thomas R, Salata RA, Rice LB. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2002; 46:3334-6.
14. Zurenko GE, Todd WM, Hafkin B, et al. Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid [abstract 848]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1999:118.
15. Herrero IA, Issa NC, Patel R. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 2002; 346: 867-9.
16. Sander P, Belova L, Kidan YG, Pfister P, Mankin AS, Bottger EC. Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations. Mol Microbiol 2002; 46:1295-304.
17. Maslow J, Slutsky AM, Arbeit RD. The application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White J, eds. Diagnostic molecular epidemiology: principles and applications. Washington, DC: American Society for Microbiology, 1993:563-72.
18. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
19. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard M7-A4. Wayne, PA: NCCLS, 2000.
20. NCCLS. Performance standards for antimicrobial disk susceptibility tests. 7th ed. Approved standard. Wayne, PA: NCCLS, 2000.
21. Pitcher DG, Saunders NA, Owen RJ. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol 1989; 8:151-6.
22. Prunier AL, Malbruny B, Tande D, Picard B, Leclercq R. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrob Agents Chemother 2002; 46:3054-6.
23. Ausubel FM, Brent R, Kingston RE, et al., eds. Short protocols in molecular biology. 3rd ed, Vol 1. New York: John Wiley & Sons, 1997.
24. Woodford N, Tysall L, Auckland C, et al. Detection of oxazolidinone-resistant Enterococcus faecalis and Enterococcus faecium strains by real-time PCR and PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 2002; 40:4298-300.
25. Colca JR, McDonald WG, Waldon DJ. Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics. J Biol Chem 2003; 278:21972-9.
26. Prammananan T, Sander P, Springer B, Bottger EC. RecA-mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrob Agents Chemother 1999; 43:447-53.
27. Lobritz M, Hutton-Thomas R, Marshall S, Rice LB. Recombination proficiency influences frequency and locus of mutational resistance to linezolid in Enterococcus faecalis. Antimicrob Agents Chemother 2003; 47:3318-20.
28. Bobkova EV, Yan YP, Jordan DB, Kurilla MG, Pompliano DL. Catalytic properties of mutant 23S ribosomes resistant to oxazolidinones. J Biol Chem 2003; 278:9802-7.
29. Howe RA, Noel A, Bowker KE, Enne VI, Walsh TR, MacGowan AP. Emergence of linezolid (LIN) resistance in Staphylococcus aureus can be associated with loss of erythromycin (ERY) resistance [abstract C1-1608]. In: Program and abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2002:75.
30. Sakoulas G, Gold HS, Venkataraman L, Moellering RC Jr, Ferraro MJ, Eliopoulos GM. Introduction of erm(C) into a linezolid- and methicillin- resistant Staphylococcus aureus does not restore linezolid susceptibility. J Antimicrob Chemother 2003; 51:1039-41.